XRF Scientific (XRF) H2 2024 earnings summary

Executive summary

• Achieved record revenue of $60.1m, surpassing $60m for the first time, with NPAT up 16% to $9.5m year-over-year.

• All core divisions performed strongly, with international sales growth in Europe, Asia, and the Americas.

• Fully franked final dividend of 3.9 cents per share declared, up 18% from last year.

• Completed acquisition of the remaining 50% of Orbis Mining post year-end, fully integrating it into operations.

Financial highlights

• Revenue increased 9% to $60.1m compared to $55.3m in FY23.

• Net profit after tax rose 16% to $9.5m; basic and diluted EPS up 15% to 6.4 cents.

• Operating cash flow was $8.1m, down 4% year-over-year.

• Gross profit margin improved to $26.5m from $23.0m.

• Cash at year-end was $12.0m, with $1.6m in debt.

Outlook and guidance

• Focus on geographic expansion, new product development, and potential acquisitions in adjacent sectors.

• Expectation of continued growth in Orbis Mining and new product launches in FY25.

• Anticipated positive impact from lower lithium input prices on working capital.